Patents by Inventor Kailash Singh

Kailash Singh has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240072803
    Abstract: A circuit provides fail safe protection of an input/output (I/O) circuit of a chip. The I/O circuit comprises an I/O pad connected to one or more other chips via an I/O bus. The circuit comprise a supply and failsafe detector component. The supply and failsafe detector component generates an I/O supply output signal. The I/O supply output signal has a low voltage value when the I/O supply voltage of the chip is below a medium voltage level and the I/O supply output signal having a high voltage value when the I/O supply voltage of the chip is above the medium voltage level. The medium voltage is above a threshold voltage of the transistor of the I/O circuit and below the high voltage value. The circuit uses the I/O supply output signal to provide a reference voltage as input to the transistor of the I/O circuit.
    Type: Application
    Filed: August 31, 2022
    Publication date: February 29, 2024
    Inventors: Kailash Kumar, Prateek Singh, Akhil Thotli
  • Publication number: 20230099367
    Abstract: The subject invention pertains to methods and compositions for treating hypertension. In specific embodiments, the methods comprise administering KSD179019 to a subject in need of hypertension treatment. In further embodiments, the methods comprise administering a KSD179019 analog or derivative to a subject in need of hypertension treatment. Also provided are methods to design and manufacture KSD179019 analogs and derivatives with enhanced and prolonged anti-hypertensive therapeutic efficacy.
    Type: Application
    Filed: April 15, 2020
    Publication date: March 30, 2023
    Inventors: Kailash SINGH, Billy Kwok Chong CHOW
  • Publication number: 20220401435
    Abstract: Compounds that have antiallergic and/or anti-inflammatory properties and methods of making thereof are disclosed. These compounds can block MMRGPRX2 and prevent or reduce mast cells activation. Pharmaceutical formulations in a unit dosage form suitable for the delivery of the compounds to a subject in need thereof are disclosed. The pharmaceutical formulations may include one or more active agents in addition to the compounds, such as one or more additional antiallergic and/or anti-inflammatory agents. The pharmaceutical formulation can be administered by oral administration, parenteral administration, inhalation, mucosal administration, or a combination thereof. Methods for preventing or treating pseudo allergic reactions, pseudo allergic diseases, and/or pseudo inflammatory diseases, or treating or ameliorating one or more symptoms associated with a pseudo allergic reaction, a pseudo allergic disease, and/or a pseudo inflammatory disease in a subject are also disclosed.
    Type: Application
    Filed: May 31, 2021
    Publication date: December 22, 2022
    Inventors: Mukesh Kumar, Kailash Singh, Billy Kwok Chong Chow
  • Patent number: PP10935
    Abstract: A new and distinct hybrid plant named `Himalaya` (Mentha arvensis) characterized by its higher yield of oil which is rich in menthol, improved regeneration potential, vigorous growth, deep green broad thick leaves, pinkish white flowers and tolerance to rust such as alternaria leaf blight, corynespora leaf spot and powdery mildew.
    Type: Grant
    Filed: April 22, 1997
    Date of Patent: June 1, 1999
    Assignee: Council of Scientific & Industrial Research
    Inventors: Sushil Kumar, Bali Ram Tyagi, Janak Raj Bahl, Hari Singh, Vikram Singh, Ram Ujagir, Suman Preet Singh Khanuja, Ajit Kumar Shasany, Ram Sajivan Shukla, Abdul Sattar, Dwijendra Singh, Akhtar Haseeb, Vijay Pal Singh, Paltoo Ram, Kambod Singh, Saudan Singh, Surendra Pratap Singh, Nirmal Kumar Patra, Mansoor Alam, Arif Ali Naqvi, Muni Ram, Krishan Kumar Agarwal, Kailash Singh